Serotonin and norepinephrine: Navigating the broad range of symptoms

Pedro L. Delgado

Serotonin and norepinephrine: Navigating the broad range of symptoms

Pedro L. Delgado

Joe R & Teresa Lozano School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Dr. Delgado emphasized that a growing body of evidence suggests that antidepressants that inhibit the re-uptake of both 5-HT and NE have the best chance to reduce most symptoms of depression by targeting the multiple pathways that mediate them in the brain and spinal cord. These neurotransmitters appear to be involved both in the therapeutic effects of antidepressants on somatic and psychiatric symptoms of depression and as mechanisms that potentially impact neurodegeneration and neuroplasticity in the brain.

Original language	English (US)
Pages (from-to)	870-872
Number of pages	3
Journal	Journal of Clinical Psychiatry
Volume	65
Issue number	6
State	Published - Jun 1 2004

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

Fingerprint Dive into the research topics of 'Serotonin and norepinephrine: Navigating the broad range of symptoms'. Together they form a unique fingerprint.

Cite this

@article{5c269b8bf2c54a7daad7163c10ffb50c,

title = "Serotonin and norepinephrine: Navigating the broad range of symptoms",

abstract = "Dr. Delgado emphasized that a growing body of evidence suggests that antidepressants that inhibit the re-uptake of both 5-HT and NE have the best chance to reduce most symptoms of depression by targeting the multiple pathways that mediate them in the brain and spinal cord. These neurotransmitters appear to be involved both in the therapeutic effects of antidepressants on somatic and psychiatric symptoms of depression and as mechanisms that potentially impact neurodegeneration and neuroplasticity in the brain.",

author = "Delgado, {Pedro L.}",

year = "2004",

month = jun,

day = "1",

language = "English (US)",

volume = "65",

pages = "870--872",

journal = "The Journal of clinical psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press Inc.",

number = "6",

}

TY - JOUR

T1 - Serotonin and norepinephrine

T2 - Navigating the broad range of symptoms

AU - Delgado, Pedro L.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Dr. Delgado emphasized that a growing body of evidence suggests that antidepressants that inhibit the re-uptake of both 5-HT and NE have the best chance to reduce most symptoms of depression by targeting the multiple pathways that mediate them in the brain and spinal cord. These neurotransmitters appear to be involved both in the therapeutic effects of antidepressants on somatic and psychiatric symptoms of depression and as mechanisms that potentially impact neurodegeneration and neuroplasticity in the brain.

AB - Dr. Delgado emphasized that a growing body of evidence suggests that antidepressants that inhibit the re-uptake of both 5-HT and NE have the best chance to reduce most symptoms of depression by targeting the multiple pathways that mediate them in the brain and spinal cord. These neurotransmitters appear to be involved both in the therapeutic effects of antidepressants on somatic and psychiatric symptoms of depression and as mechanisms that potentially impact neurodegeneration and neuroplasticity in the brain.

UR - http://www.scopus.com/inward/record.url?scp=67649499935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649499935&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67649499935

VL - 65

SP - 870

EP - 872

JO - The Journal of clinical psychiatry

JF - The Journal of clinical psychiatry

SN - 0160-6689

IS - 6

ER -